Cargando…

Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy

PURPOSE: To evaluate choroidal thickness (CTh) in children with chronic heart failure (CHF) secondary to dilated cardiomyopathy (DCM) using spectral domain optical coherence tomography (SD-OCT) and to compare their values to those of healthy children. METHODS: Sixty eyes of thirty children (mean age...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakusiewicz, Klaudia, Kanigowska, Krystyna, Hautz, Wojciech, Ziółkowska, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172512/
https://www.ncbi.nlm.nih.gov/pubmed/33966146
http://dx.doi.org/10.1007/s10792-021-01774-5
_version_ 1783702545051418624
author Rakusiewicz, Klaudia
Kanigowska, Krystyna
Hautz, Wojciech
Ziółkowska, Lidia
author_facet Rakusiewicz, Klaudia
Kanigowska, Krystyna
Hautz, Wojciech
Ziółkowska, Lidia
author_sort Rakusiewicz, Klaudia
collection PubMed
description PURPOSE: To evaluate choroidal thickness (CTh) in children with chronic heart failure (CHF) secondary to dilated cardiomyopathy (DCM) using spectral domain optical coherence tomography (SD-OCT) and to compare their values to those of healthy children. METHODS: Sixty eyes of thirty children (mean age 9.9 ± 3.57 years) with chronic heart failure (left ventricular ejection fraction, LVEF ≤ 55%) due to DCM lasting for over 6 months were prospectively enrolled. The control group consisted of 30 age- (mean age 10.16 ± 3.42 years) and sex-matched healthy children. All participants underwent transthoracic echocardiography with LVEF measured using the Simpson method and had the blood serum level of N-terminal-pro-brain natriuretic peptide marker (NT-proBNP) determined. All children underwent SD-OCT and had subfoveal choroidal thickness (SFCTh) and CTh measured at 1500 µm (μm) nasally, temporally, superiorly and inferiorly from the fovea in both eyes by two investigators. RESULTS: CTh at all locations was statistically significantly lower in children with DCM compared to the control group. Mean CTh in the group with CHF compared to the control group were (304.03 vs. 369.72 μm, p < 0.05) at the subfoveal location, (245.87 vs. 284 μm, p < 0.05) 1500 μm nasally from the fovea, (291.5 vs. 355.95 μm, p < 0.05) 1500 μm temporally from the fovea, (303.98 vs. 357.58 μm, p < 0.05) 1500 μm superiorly from the fovea and (290.92 vs. 344.96 μm, p < 0.05) 1500 μm inferiorly from the fovea. The average difference CTh between the study groups ranged from 38.13 to 65.69 μm at individual locations. In both groups, CTh was the thickest at subfoveal location (304.03 vs. 369.72 μm, p < 0.05) and the thinnest was 1500 μm nasally from the fovea (262.37 vs. 336.87 μm, p < 0.05). There was no correlation between CTh and age, gender, biometry and refractive error. No correlation was found between CTh and LVEF and NT-proBNP. CONCLUSION: Patients with CHF due to DCM had a thinner CTh at all measured locations. The results of our research indicate that CHF affects CTh and this parameter may be very helpful in monitoring the clinical course of the disease in children with DCM.
format Online
Article
Text
id pubmed-8172512
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-81725122021-06-07 Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy Rakusiewicz, Klaudia Kanigowska, Krystyna Hautz, Wojciech Ziółkowska, Lidia Int Ophthalmol Original Paper PURPOSE: To evaluate choroidal thickness (CTh) in children with chronic heart failure (CHF) secondary to dilated cardiomyopathy (DCM) using spectral domain optical coherence tomography (SD-OCT) and to compare their values to those of healthy children. METHODS: Sixty eyes of thirty children (mean age 9.9 ± 3.57 years) with chronic heart failure (left ventricular ejection fraction, LVEF ≤ 55%) due to DCM lasting for over 6 months were prospectively enrolled. The control group consisted of 30 age- (mean age 10.16 ± 3.42 years) and sex-matched healthy children. All participants underwent transthoracic echocardiography with LVEF measured using the Simpson method and had the blood serum level of N-terminal-pro-brain natriuretic peptide marker (NT-proBNP) determined. All children underwent SD-OCT and had subfoveal choroidal thickness (SFCTh) and CTh measured at 1500 µm (μm) nasally, temporally, superiorly and inferiorly from the fovea in both eyes by two investigators. RESULTS: CTh at all locations was statistically significantly lower in children with DCM compared to the control group. Mean CTh in the group with CHF compared to the control group were (304.03 vs. 369.72 μm, p < 0.05) at the subfoveal location, (245.87 vs. 284 μm, p < 0.05) 1500 μm nasally from the fovea, (291.5 vs. 355.95 μm, p < 0.05) 1500 μm temporally from the fovea, (303.98 vs. 357.58 μm, p < 0.05) 1500 μm superiorly from the fovea and (290.92 vs. 344.96 μm, p < 0.05) 1500 μm inferiorly from the fovea. The average difference CTh between the study groups ranged from 38.13 to 65.69 μm at individual locations. In both groups, CTh was the thickest at subfoveal location (304.03 vs. 369.72 μm, p < 0.05) and the thinnest was 1500 μm nasally from the fovea (262.37 vs. 336.87 μm, p < 0.05). There was no correlation between CTh and age, gender, biometry and refractive error. No correlation was found between CTh and LVEF and NT-proBNP. CONCLUSION: Patients with CHF due to DCM had a thinner CTh at all measured locations. The results of our research indicate that CHF affects CTh and this parameter may be very helpful in monitoring the clinical course of the disease in children with DCM. Springer Netherlands 2021-05-09 2021 /pmc/articles/PMC8172512/ /pubmed/33966146 http://dx.doi.org/10.1007/s10792-021-01774-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Rakusiewicz, Klaudia
Kanigowska, Krystyna
Hautz, Wojciech
Ziółkowska, Lidia
Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
title Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
title_full Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
title_fullStr Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
title_full_unstemmed Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
title_short Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
title_sort choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172512/
https://www.ncbi.nlm.nih.gov/pubmed/33966146
http://dx.doi.org/10.1007/s10792-021-01774-5
work_keys_str_mv AT rakusiewiczklaudia choroidalthicknesschangesinchildrenwithchronicheartfailureduetodilatedcardiomyopathy
AT kanigowskakrystyna choroidalthicknesschangesinchildrenwithchronicheartfailureduetodilatedcardiomyopathy
AT hautzwojciech choroidalthicknesschangesinchildrenwithchronicheartfailureduetodilatedcardiomyopathy
AT ziołkowskalidia choroidalthicknesschangesinchildrenwithchronicheartfailureduetodilatedcardiomyopathy